相关实验视频
Updated: Jun 22, 2025

12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
12.6K
在治疗B细胞恶性瘤时利用改变的脂质代谢
Jaewoong Lee1, Arya Mani2, Min-Jeong Shin3
1School of Biosystems and Biomedical Sciences, College of Health Science, Korea University, Seoul 02841, Republic of Korea; Department of Integrated Biomedical and Life Science, Korea University, Seoul 02841, Republic of Korea; Interdisciplinary Program in Precision Public Health, Korea University, Seoul 02841, Republic of Korea; Center of Molecular and Cellular Oncology, Yale University, New Haven, CT 06511, USA.
Progress in lipid research
|July 4, 2024
概括
改变的脂质代谢通过影响细胞生长和存活来推动B细胞恶性瘤. 针对这些代谢变化提供了治疗这些血液癌症的新策略.
科学领域:
- 在瘤学瘤学.
- 癌症新陈代谢 癌症新陈代谢
- 血液学 血液学 血液学
背景情况:
- B细胞恶性瘤是80多种血液癌症,具有复杂的信号传导.
- 脂肪代谢中断越来越被认为是它们发育的关键因素.
- 异常的脂类物种有助于不受控制的繁殖和生存.
研究的目的:
- 审查脂质代谢在B细胞恶性瘤中的作用.
- 要突出内在和外在因素如何重编程脂质代谢.
- 探索向脂质代谢的翻译潜力.
主要方法:
- 文献综述和关于B细胞恶性瘤中的脂质代谢的证据综合.
- 分析各种脂类物种 (脂,胆固醇,脂,脂肪酸) 的影响.
- 检查外部因素,如肥胖和遗传驱动因素 (例如,MYC).
主要成果:
- 脂,胆固醇,脂和脂肪酸在B细胞恶性瘤中发生变化.
- 脂质对于瘤信号传播至关重要.
- 肥胖和遗传因素进一步破坏脂质代谢的调节,促进了侵略性的表型.
- 改变的脂质代谢支持不受控制的增殖,生存和治疗逃避.
结论:
- 内在和外在因素在B细胞恶性瘤中重编程脂质代谢.
- 准脂质代谢是一种有前途的治疗策略.
- 这种方法可以改善B细胞癌的风险分层和临床管理.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509

